← back to search

Domingo A. Pascual‐Figal

Instituto de Salud Carlos III ·
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, and Transplantation: Methods and Outcomes.
h-index
63
citations
14,223
works
506
NIH funding
primary concept
Medicine
email

Recent publications

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction
New England Journal of Medicine 2025cited by 81position: middledoi
Colchicine for secondary prevention of vascular events: a meta-analysis of trials
European Heart Journal 2025cited by 41position: middledoi
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis
Heart Failure Reviews 2025cited by 13position: middledoi
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial
Circulation 2024cited by 53position: middledoi
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials
EClinicalMedicine 2024cited by 53position: middledoi
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
European Heart Journal 2021cited by 106position: middledoi
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European Heart Journal - Cardiovascular Pharmacotherapy 2021cited by 62position: middledoi
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
The Lancet 2020cited by 751position: middledoi
Effect of low‐dose colchicine in acute and chronic coronary syndromes: A systematic review and meta‐analysis
European Journal of Clinical Investigation 2020cited by 35position: middledoi
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
Circulation 2019cited by 341position: middledoi
Rationale and Design of the AFFIRM-AHF Trial: A Randomised, Double-Blind, Placebo-Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron-Deficient Patients Admitted for Acute Heart Failure
European Journal of Heart Failure 2019cited by 53position: middledoi
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
Journal of the American College of Cardiology 2018cited by 297position: middledoi
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
JACC Heart Failure 2017cited by 154position: middledoi
The Biology of ST2: The International ST2 Consensus Panel
The American Journal of Cardiology 2015cited by 308position: firstdoi
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World
Journal of the American College of Cardiology 2013cited by 251position: middledoi
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study
International Journal of Cardiology 2013cited by 237position: middledoi
Association Between Elevated Blood Glucose and Outcome in Acute Heart Failure
Journal of the American College of Cardiology 2013cited by 121position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

James L. Januzzi · Sentara Heart Hospital4 papers (2013–2017)Johan Lassus · University of Helsinki3 papers (2013–2017)Étienne Gayat · Assistance Publique – Hôpitaux de Paris3 papers (2013–2017)Alexandre Mebazaa · Helix (United States)3 papers (2013–2017)Marco Metra · Mylan (South Africa)3 papers (2013–2019)Alain Cohen‐Solal · Inserm2 papers (2013–2013)Alberto Aimo · University College London2 papers (2017–2020)Naoki Sato · British Heart Foundation2 papers (2013–2013)Christian Mueller · University of Lübeck2 papers (2013–2013)Jiří Pařenica · Masaryk University2 papers (2013–2013)Antoni Bayés‐Genís · INCLIVA Health Research Institute2 papers (2017–2020)Michele Emdin · Sequoia (United States)2 papers (2017–2020) · 2 papers (2013–2013) · 2 papers (2013–2013) · 2 papers (2013–2013)Jamie Layland · Australian Regenerative Medicine Institute1 papers (2025–2025)Peter J. Kelly · University College Dublin1 papers (2025–2025) · 1 papers (2025–2025)Ewa A. Jankowska · Wroclaw Medical University1 papers (2019–2019) · 1 papers (2013–2013)